European Medical Imaging Markets

Published: May 2011
No. of Pages: 110
Price: $ 3400







The European market for medical imaging equipment continues to thrive despite the impact of a global economic recession. As such, the European medical imaging market represents a dynamic and robust sector which will progressively represent an increasingly important sub-market within the medical device business. In order to provide a comprehensive and relevant analysis of the European medical imaging market, this TriMark Publications report covers the major medical imaging modalities of computed tomography (CT), magnetic resonance imaging (MRI), positron emission tomography (PET), single photon emission computed tomography (SPECT) and ultrasound. In order to reflect the ongoing shifts in the utilization of the modalities from single to multimodality systems, this study also includes analyzes of the European markets for PET/CT and SPECT/CT.

Browse All: Pharmaceutical Market Research

While the European medical imaging market is dominated by a handful of multinational players, this report surveys almost all of the companies known to be marketing, manufacturing or developing medical imaging equipment and supplies in France, Germany, Italy, Spain, the United Kingdom, the Benelux countries, Scandinavia and the rest of Europe (ROE). Each company is discussed in extensive depth with a section on its history, product line, business and marketing analysis, and a subjective commentary of the company’s market position. Detailed tables and charts with sales forecasts and market data are also included. To complete the analysis of the European market, this report also reviews other factors which are instrumental in shaping the future direction of Europe's medical imaging sector. The study looks at pricing, reimbursement issues, provides an assessment of the purchasing processes for capital equipment in each target market, and reviews alternative funding methods for capital equipment purchases and the regulatory environment with its inherent issues and challenges.
 

Nuclear Cardiology Markets

Published: May 2011
No. of Pages: 252
Price: $ 3400







Nuclear imaging for cardiac diseases helps in accurately diagnosing the disease and blood flow blockages. Gamma cameras and positron emission tomography (PET) scanners are the key imaging devices used for cardiac procedures. Though nuclear imaging in cardiology faces competition from other methods, the impact is relatively limited. Demand for diagnostic medical imaging equipment is mainly driven by the number of diagnostic procedures. The application of PET's clinical use, its combined use with other imaging equipment and the current shift to PET/CT imaging and SPECT/CT imaging are the important factors driving the dramatic rise in procedural volumes.

This TriMark Publications study discusses key products in nuclear cardiology and examines the trends that are stimulating this market. This market research report includes a survey of all major companies actively engaged in marketing, manufacturing or developing nuclear cardiological instrumentation, with each company discussed in depth. The primarily focus on three major segments of the nuclear cardiology market: 1) devices, 2) PACS (picture archiving and communications systems) and RIS (radiology information systems) and 3) radiopharmaceuticals. This examination discusses products, trends, new developments and compensation issues that are currently affecting or are likely to affect the nuclear cardiology market soon. Detailed tables and charts with sales forecasts and market share data are also included.

Browse All: Pharmaceuticals Market Research Reports

Table Of Contents

1. Overview
1.2 Scope
1.3 Methodology
1.4 Executive Summary

2. Overview of Cardiovascular Diseases (CVD)
2.1 Heart Diseases in Men
2.2 Heart Diseases in Women
2.3 Prevalence of Cardiovascular Diseases in the U.S.
2.3.1 Prevalence of CVD in Ethnic Groups: U.S.
2.3.2 Global CVD Mortality
2.3.3 Economic Cost of CVD in the U.S.
2.3.4 CVD Mortality in Europe
2.4 CVD Mortality in China
2.5 CVD Prevalence and Mortality in India
2.6 Aneurysm
2.6.1 Detection of Aneurysm
2.7 Angina
2.7.1 Prevalence of Angina
2.8 Atherosclerosis
2.8.1 Imaging of Atherosclerosis
2.9 Cerebrovascular Accident (Stroke)
2.9.1 Embolic Stroke
2.9.2 Cerebral Hemorrhage
2.9.3 Subarachnoid Hemorrhage
2.9.4 Imaging Devices Used for Detecting Stroke
2.10 Congestive Heart Failure
2.10.1 Imaging Modalities Used for the Detection of Congestive Heart Failure
2.11 Coronary Artery Disease (CAD)
2.11.1 Imaging of CAD
2.12 Nuclear Imaging for Heart Diseases
2.12.1 Technological Advances in Nuclear Cardiology
2.12.1.1 Development of New Pharmacologic Stress Agents and Protocols
2.12.1.2 Development of New Tracers
2.12.1.3 New Computer Algorithms and Tools
2.12.1.3 New Gamma Camera Technology
2.12.1.4 Hybrid Systems and Image Fusion
2.13 Trends in Cardiac Imaging

3. Popular Modalities Used in Nuclear Cardiology
3.1 SPECT/CT
3.1.1 General Architecture of SPECT/CT
3.1.2 Myocardial Perfusion Imaging: CT Based Attenuation Correction
3.1.4 SPECT/CT for Cardiac Disease Detection: An Economic Conundrum
3.1.4.1 SPECT/CT from the Physician’s Point of View
3.1.4.2 Cost Effectiveness vs. Cost and Reimbursement
3.1.4.3 Factors to Drive Sales and Utilization of SPECT/CT
3.1.4.4 Newer SPECT Cameras
3.1.4.5 New Ultrafast Camera Designs
3.1.4.6 Basic Design of a Gamma Camera
3.2 Positron Emission Tomography (PET)
3.2.1 Basic Design of a PET System
3.2.2 Application of PET in Cardiology
3.2.3 PET and Heart Disease Diagnosis
3.2.4 PET and Heart Disease Staging
3.2.5 Reimbursement Cuts for Cardiac PET in 2011
3.2.6 Growth of PET in Cardiology
3.2.6.1 PET/CT Hybridization
3.2.6.2 Cost Considerations in PET Scanners
3.2.7 PET/CT in Cardiology
3.2.7.1 Positron Emitting Tracers
3.3.1 The Resting Electrocardiogram (ECG)
3.3.2 The Exercise Stress Test (Treadmill Stress Test, TMT)
3.3.3 Echocardiography
3.3.4 Magnetic Resonance Imaging (MRI)
3.3.5 Multi-slice Computed Tomography (MSCT)
3.3.6 Contrast Coronary Angiography (CA) and Intravascular Ultrasound (IVUS)

4. Nuclear Medicine
4.1 Diagnostic Radiopharmaceuticals
4.2 Suppliers of Radioisotopes
4.3 Isotopes Used in Medicine
4.4 Cyclotron Radioisotopes
4.5 Radiopharmaceuticals in PET Imaging
4.6 Radiopharmaceuticals for Clinical Cardiac PET Imaging
4.6.1 Nitrogen-13 Ammonia
4.6.2 Rubidium-82
4.6.3 Oxygen-15 Water
4.6.4 Fluorine-18 Fluorodeoxyglucose
4.7 Generator Produced PET Radiopharmaceuticals
4.8 Radiopharmaceuticals in SPECT

5. Picture Archiving and Communication Systems (PACS) in Cardiology
5.1 Trends in Cardiology PACS
5.1.1 Remote Reading of PACS
5.1.2 Double-Digit Growth in CardioPACS

6. Advances in Nuclear Cardiology
6.1 Myocardial Function
6.2 Myocardial Perfusion
6.3 Gated Myocardial Perfusion SPECT
6.4 Advances in Software for Gated SPECT
6.5 Gated Myocardial Perfusion SPECT in the Era of Multi-Detector CT
6.6 PET and Imaging of Myocardial Metabolism
6.7 Imaging Myocardial Innervation
6.8 Radionuclide Imaging of Atherosclerotic Lesions
6.9 Stem Cell Imaging
6.10 Gene Therapy

Ultrasound Markets

Published: June 2011
No. of Pages: 248
Price: $3400







Ultrasound represents a low-cost and efficacious imaging technology that continues to help radiologists and others collect significant clinical data about patients. Ultrasound is appropriately suited to many patients. No other imaging modality gives patients a real-time viewing at their anatomy or inspires discussions with physicians about their symptoms and the evidence of disease on the monitor. Ultrasound is radiation-free, patient-friendly and less-expensive.

The adoption of this modality by all categories of hospitals and other healthcare institutions has given rise to new market opportunities for manufacturers of ultrasound systems and components suppliers. Ultrasound imaging systems have become conventional in almost all the offices of cardiologists, obstetricians, surgeons and urologists among other specialists. New uses, such as the applications of ultrasound in dispensing emergency medicine, along with new hand-held portable systems are helping to further propel the medical marketplace for the technology. This TriMark Publications report Ultrasound Markets surveys almost all of the companies known to be marketing, manufacturing or developing ultrasound equipment and supplies in the world. Each company is discussed in extensive depth with a section on its history, product line, business and marketing analysis, and a subjective commentary of the company's market position. Detailed tables and charts with sales forecasts and market data are also included. 

Table of Contents

1. Overview
1.1 Statement of Report
1.2 Scope of the Report
1.3 Methodology
1.4 Executive Summary

2. Ultrasound Systems: An Overview
2.1 Portable Ultrasound
2.2 Compact Ultrasound
2.2.1 Expanding Clinical Roles for Compact Ultrasound Systems
2.2.1.1 Aloka
2.2.1.2 Biosound Esaote
2.2.1.3 GE Healthcare
2.2.1.4 Hitachi Medical Systems
2.2.1.5 Medison
2.2.1.6 Philips Medical Systems
2.2.1.7 Siemens Medical Solutions
2.2.1.8 SonoSite
2.2.1.9 TeraRecon
2.2.1.10 Terason
2.2.1.11 Toshiba America Medical Systems
2.2.1.12 Zonare Medical Systems
2.3 Cost of Compact Ultrasound Imaging Systems
2.4 Accuracy of Compact Ultrasound Systems
2.5 Ease of Use of Compact Ultrasound Systems
2.6 Multi-Site Imaging of Compact Ultrasound Imaging Systems
2.7 Choosing the Right Ultrasound Machine
2.7.1 Features to be Considered
2.7.2 Technical Specifications
2.7.3 Stationary vs. Mobile
2.7.4 Financing
2.7.5 New vs. Refurbished
2.7.6 Warranty/Service Plans
2.7.7 Finding the Best Ultrasound Machine
2.8 The Working of Ultrasound Systems
2.8.1 The Ultrasound Machine
2.9 Components of Ultrasound Imaging Systems
2.9.1 Transducers
2.9.2 High-Voltage Multiplexing
2.9.3 High-Voltage Transmitters
2.9.4 Image-Path Receivers
2.9.5 Tx/Rx Switch
2.9.6 Low-Noise Amplifier (LNA)
2.9.7 Variable-Gain Amplifier (VGA)
2.9.8 Anti-Alias Filter (AAF) and ADC
2.9.9 Digital Beamformers
2.9.10 Beamformed Digital-Signal Processing
2.9.11 Color-Flow Processing
2.9.12 Display Processing
2.10 Different Types of Ultrasound
2.10.1 3D/4D Ultrasound
2.10.1.1 Equipment Design
2.10.1.2 Purchase Considerations
2.10.1.3 Acquisition Approaches
2.10.1.4 Display Strategies
2.11 Endoscopic Ultrasound
2.12 Handheld Ultrasound Imaging Device
2.13 Diagnosis of Possible Diseases with Ultrasound Imaging Units
2.14 Major Uses of Ultrasound
2.14.1 Ultrasound Scanners by Specialty
2.14.1.1 Ultrasound Imaging in Gynecology/Obstetric
2.14.1.2 Fetal Testing (Nuchal Translucency Testing, 11-14 Weeks)
2.14.1.3 4D Ultrasound (26 Weeks)
2.14.2 Ultrasound Imaging in Urology
2.14.2.1 Bladder Ultrasound
2.14.2.2 Kidney Ultrasound
2.14.2.3 Scrotum Ultrasound
2.14.2.4 Prostrate Ultrasound and Biopsy
2.14.3 Ultrasound for Musculoskeletal Disorders
2.14.4 Ultrasound Imaging in Interventional Radiology
2.14.5 Ultrasound Imaging for Breast Examination
2.14.6 Echocardiography
2.14.7 Sonoelastography
2.14.8 Ultrasound Therapy for Cosmetic Purposes
2.14.8.1 Focused Ultrasound Body Contouring
2.14.8.2 VASER Liposuction
2.14.9 Ultrasound Brow Lift
2.14.10 3D Ultrasound Imaging in Pregnancy
2.14.11 Abdominal Ultrasound
2.14.12 Cardiac Ultrasound
2.14.13 Portable Ultrasound
2.15 Limitations of General Ultrasound Imaging